ID2 and acute myeloid leukemia: In order to analyze clinical relevance of ID2 expression in AML, the whole-cohort AML patients were divided into two groups (ID2high and ID2low) by the cut-off value (defined due to the sensitivity+specificity-1 was the highest value) based on ROC analysis.